ACAD
31.77
-0.8
-2.46%
AEMD
0.26
+0.01
+2.00%
APRI
1.22
-0.02
-1.61%
ARNA
4.52
-0.14
-3.00%
ATEC
1.36
+0.01
+0.74%
CFN
59.75
-0.23
-0.38%
CNAT
5.34
+0.02
+0.38%
CRXM
0.2
+0.02
+11.11%
CYTX
0.47
-0.01
-1.19%
DXCM
57.92
-0.19
-0.33%
GNMK
13.18
+0.09
+0.69%
HALO
13.89
-0.12
-0.86%
ILMN
196.69
+2.8
+1.44%
INNV
0.25
+0.01
+4.17%
INO
8.62
+0.12
+1.41%
ISCO
0.06
0.00
0.00%
ISIS
71.25
+0.27
+0.37%
LGND
54.86
-0.97
-1.74%
LPTN
2.97
0.00
0.00%
MBVX
1.1
-0.15
-12.00%
MEIP
3.69
-0.1
-2.64%
MNOV
3.52
-0.12
-3.17%
MRTX
19.27
-0.15
-0.77%
MSTX
0.48
+0.00
+0.04%
NBIX
31.71
+0.13
+0.41%
NUVA
46.93
-0.26
-0.55%
ONCS
0.4
+0.00
+0.25%
ONVO
6.32
-0.05
-0.78%
OREX
5.4
+0.12
+2.27%
OTIC
32.83
+3.49
+11.90%
QDEL
24.26
-0.04
-0.16%
RCPT
110.23
+3.01
+2.80%
RGLS
18.53
+0.27
+1.48%
RMD
65.44
+3.58
+5.79%
SCIE
0.01
0.00
-7.75%
SPHS
0.45
+0.00
+1.02%
SRNE
9.96
-0.03
-0.30%
TROV
5.82
0.00
-0.06%
VICL
1.04
+0.01
+0.96%
VOLC
17.96
+0.01
+0.06%
ZGNX
1.34
+0.05
+3.88%
Home » Archive by Category

News

San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

Shares Rise After Otonomy’s $100M IPO

August 13, 2014 – 4:08 pm | Edit Post

Shares of Otonomy Inc. were rising Aug. 13 after the biotech drug developer’s initial public offering raised $100 million.

New Blood: Tracing the Beginnings of Hematopoietic Stem Cells

August 13, 2014 – 2:36 pm | Edit Post
New Blood: Tracing the Beginnings of Hematopoietic Stem Cells

In a paper published online this week in Nature, researchers at the University of California, San Diego School of Medicine elaborate upon a crucial signaling pathway and the role of key proteins, which may help clear the way to generate …

Otonomy completes $100 million IPO

August 13, 2014 – 9:37 am | Edit Post

San Diego developer of ear disease drugs sells $6.25 million shares for $16 each.

Otonomy completes $100 million IPO

August 13, 2014 – 9:37 am | Edit Post

San Diego developer of ear disease drugs sells $6.25 million shares for $16 each.

Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

August 13, 2014 – 8:47 am | Edit Post
Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

San Diego-based Organovo (NYSE: ONVO) says a three-dimensional sample of living human liver tissue created with its bio-printing technology was used successfully for the first time to predict that a…

[[Click headline to continue reading.]]

Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

August 13, 2014 – 8:47 am | Edit Post
Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

San Diego-based Organovo (NYSE: ONVO) says a three-dimensional sample of living human liver tissue created with its bio-printing technology was used successfully for the first time to predict that a…

[[Click headline to continue reading.]]

Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

August 13, 2014 – 8:47 am | Edit Post
Organovo to Offer Preclinical Drug Tests Based on 3-D Liver Tissue

San Diego-based Organovo (NYSE: ONVO) says a three-dimensional sample of living human liver tissue created with its bio-printing technology was used successfully for the first time to predict that a…

[[Click headline to continue reading.]]

Single gene controls jet lag

August 12, 2014 – 5:00 pm | Edit Post

LA JOLLA–Scientists at the Salk Institute for Biological Studies have identified a gene that regulates sleep and wake rhythms.

Single gene controls jet lag

August 12, 2014 – 5:00 pm | Edit Post

LA JOLLA–Scientists at the Salk Institute for Biological Studies have identified a gene that regulates sleep and wake rhythms.

Single gene controls jet lag

August 12, 2014 – 5:00 pm | Edit Post

LA JOLLA–Scientists at the Salk Institute for Biological Studies have identified a gene that regulates sleep and wake rhythms.